off label uses for tirzepatide Mounjaro Injection Nomida Tirzepatide 10ml Vial Label

most other claimed benefits (bone density, body composition) trace back to animal studies or preliminary/anecdotal reports, not confirmed human efficacy trials

It is not indicated for type 1 diabetes and is not recommended in patients with severe gastrointestinal disease

FDA-Approved Indications for Zepbound: Adults with obesity (BMI 30 kg/m)

The medication works best when combined with sustainable lifestyle changes including regular physical activity and balanced nutrition

Statistical methods Statistical analysis was conducted using One-way or Two-way ANOVA followed by Tukeys or Sidaks multiple comparison test or using Students t -test as specified in figure legends

It is common for people to notice: Less of an appetite Needing less food to feel full Smaller portions Less frequent food cravings Some people even reported the beginning of weight loss during this adjustment